Carlyle, Brighton Park invest $200 million in drug development firm Indegene

020421 Carlyle, Brighton Park invest $20
Download • 78KB

"Carlyle's commitment to the healthcare sector with their global network and deep pharmaceutical expertise, coupled with Brighton Park's deep experience in the technology sector and nuanced understanding of our space, makes the two ideal partners to support our company's continued growth," said Manish Gupta, Co-Founder and CEO of Indegene..."

Medical and Pharma Insider

A Program of FC Global Strategies LLC

383 Corona Street, Suite 589, Denver CO 80218 USA

Tel +1 303 478 4887



MedicalandPharmaInsider- (1).jpg
FC Global Strategies.png

©2021 Medical and Pharma Insider and FC Global Strategies LLC